Selected article for: "arachidonic acid and endothelial cell"
Author: Das, Undurti N.
Title: Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19?
  • Cord-id: uesry4z7
  • Document date: 2020_8_19
    • ID: uesry4z7
    Snippet: It is proposed that the bioactive lipid, arachidonic acid (AA, 20:4 n-6), can inactivate severe acute respiratory syndrome(SARS-CoV-2), facilitate M1 and M2 macrophage generation, suppress inflammation, prevent vascular endothelial cell damage, and regulate inflammation resolution processes based on the timely formation of prostaglandin E2 (PGE2) and lipoxin A4 (LXA4) based on the context. Thus, AA may be useful both to prevent and manage coronavrus disease-2019(COVID-19).
    Document: It is proposed that the bioactive lipid, arachidonic acid (AA, 20:4 n-6), can inactivate severe acute respiratory syndrome(SARS-CoV-2), facilitate M1 and M2 macrophage generation, suppress inflammation, prevent vascular endothelial cell damage, and regulate inflammation resolution processes based on the timely formation of prostaglandin E2 (PGE2) and lipoxin A4 (LXA4) based on the context. Thus, AA may be useful both to prevent and manage coronavrus disease-2019(COVID-19).

    Search related documents:
    Co phrase search for related documents
    • acute respiratory distress syndrome and administration sars infection: 1
    • acute respiratory distress syndrome and adrenal gland: 1
    • acute respiratory distress syndrome and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
    • acute respiratory distress syndrome and liver support: 1, 2, 3, 4, 5, 6
    • acute respiratory distress syndrome and liver support system: 1
    • acute respiratory distress syndrome and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lox lipoxygenase: 1
    • acute respiratory distress syndrome and lymph node: 1, 2
    • acutely ill and low molecular: 1, 2, 3, 4, 5
    • adipose tissue and adrenal gland: 1, 2, 3, 4
    • adipose tissue and adrenal gland bladder: 1
    • adipose tissue and adrenal gland bladder liver: 1
    • adipose tissue and adrenal gland bladder liver colon: 1
    • adipose tissue and liver failure: 1
    • adipose tissue and liver support: 1
    • adipose tissue and low molecular: 1
    • adipose tissue and lymph node: 1, 2, 3, 4
    • administration sars infection and low molecular: 1
    • adrenal gland and lymph node: 1, 2, 3, 4, 5, 6